<DOC>
	<DOCNO>NCT00611104</DOCNO>
	<brief_summary>RATIONALE : Estrogen cause growth breast cancer cell . Studying sample blood urine laboratory participant receive freeze-dried table grape powder may help doctor understand effect drug blood estrogen level . PURPOSE : This clinical trial study effect freeze-dried table grape powder blood estrogen level postmenopausal woman .</brief_summary>
	<brief_title>Studying Effect Freeze-Dried Table Grape Powder Blood Estrogen Levels Postmenopausal Women</brief_title>
	<detailed_description>OBJECTIVES : - To measure change level plasma estrone ( E1 ) , estradiol , E1-conjugates , E1-sulfates postmenopausal woman 6 week daily ingestion 94 gram freeze-dried table grape powder . - To conduct bioavailability research freeze-dried table grape powder human analysis participant ' blood urine sample . OUTLINE : Participants receive oral freeze-dried table grape powder daily day 1-42 addition usual diet . Treatment continue absence toxicity . Participants undergo blood sample collection baseline , periodically first dose , last day study pharmacokinetic bioavailability analysis . Samples examine mass spectrometry measure plasma level estrone ( E1 ) , estradiol , E1-conjugates , E1-sulfates , testosterone , androstenedione . Participants also undergo spot urine collection weight height measurement periodically study . Participants complete food diary day 1-3 , 21-23 , 40-42 ass intake grape , grape juice , red wine examine constancy caloric intake course study .</detailed_description>
	<criteria>DISEASE CHARACTERISTICS : Participant Mayo Mammography Health Study Has consent provide baseline mammogram digitization PATIENT CHARACTERISTICS : ECOG performance status 01 Female Postmenopausal ( define woman ovary remove menstrual period least 12 consecutive month ) Able give inform consent complete food record alone assistance Willing provide research blood urine sample Must nonsmoker Willing maintain current weight No history breast ductal carcinoma situ cancer , except basal cell squamous cell skin cancer lobular carcinoma situ No history allergic adverse reaction grapes No history diabetes glucose intolerance PRIOR CONCURRENT THERAPY : No concurrent hormone therapy , include estradiol , estrone , progestin</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>120 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>breast cancer</keyword>
</DOC>